Biogen News

Biogen Analyst Ratings

Benzinga14:01 ET

HC Wainwright Adjusts Biogen's Price Target to $300 From $325

MT NewswiresApr 25 07:39 ET

Truist Financial Reaffirms Their Buy Rating on Biogen (BIIB)

TipRanksApr 25 07:10 ET

Wedbush Adjusts Price Target on Biogen to $215 From $213

MT NewswiresApr 25 06:48 ET

Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Biogen (BIIB) and Molina Healthcare (MOH)

TipRanksApr 25 05:40 ET

Biogen Analyst Ratings

BenzingaApr 25 05:31 ET

RBC Lowers Biogen's Price Target to $317 From $326

MT NewswiresApr 24 13:25 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Boston Scientific (BSX) and Biogen (BIIB)

TipRanksApr 24 09:10 ET

Biogen Analyst Ratings

BenzingaApr 24 08:32 ET

Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Biogen (BIIB) and Neurocrine (NBIX)

TipRanksApr 24 05:42 ET

Piper Sandler Sticks to Its Buy Rating for Biogen (BIIB)

TipRanksApr 22 08:28 ET

Biogen Analyst Ratings

BenzingaApr 19 10:51 ET

Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB)

TipRanksApr 19 07:50 ET

Biogen Analyst Ratings

BenzingaApr 17 12:54 ET

Biogen Analyst Ratings

BenzingaApr 12 07:59 ET

Biogen Analyst Ratings

BenzingaApr 11 08:48 ET

Biogen Analyst Ratings

BenzingaApr 4 09:19 ET

Buy Rating on Biogen: Focused on Leqembi's IV Dosing Amidst SQ Formulation Delay

TipRanksApr 1 09:45 ET

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT) and Biogen (BIIB)

TipRanksApr 1 08:10 ET

Hold Rating on Biogen Amidst Leqembi's Regulatory Challenges and Competitive Pressures

TipRanksApr 1 05:26 ET